Thomas Pudlarz

Villejuif, 94805, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians.

Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians.

Journal: British journal of cancer

Published: August 31, 2026

Third-line treatment of biliary tract cancers in a real-life setting.

Third-line treatment of biliary tract cancers in a real-life setting.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK Biobank.

Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK Biobank.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 18, 2026

Integrating tumor volumetry and liquid biopsy: a New model to define prognosis in advanced pancreatic ductal adenocarcinoma.

Integrating tumor volumetry and liquid biopsy: a New model to define prognosis in advanced pancreatic ductal adenocarcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 01, 2026

Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patients.

Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patients.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.

Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.

Journal: British journal of cancer

Published: January 20, 2026

Anti-Epidermal Growth Factor Receptor Therapy in EGFR-Amplified Esophagogastric Cancers: An Underestimated Efficacy.

Anti-Epidermal Growth Factor Receptor Therapy in EGFR-Amplified Esophagogastric Cancers: An Underestimated Efficacy.

Journal: JCO precision oncology

Published: December 10, 2025

Lung-only metastatic pancreatic cancer: Differences in patients 'characteristics, molecular profile and survival.

Lung-only metastatic pancreatic cancer: Differences in patients 'characteristics, molecular profile and survival.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 04, 2025

The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma.

The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma.

Journal: Cancers

Published: November 12, 2025

Screening and prevention of second primary cancers by hospital-based oncology professionals.

Screening and prevention of second primary cancers by hospital-based oncology professionals.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: November 10, 2025

Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment.

Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 11, 2025

Targeting the liver: Insights from a tertiary center on post-operative hepatic arterial oxaliplatin for metastatic colorectal cancer.

Targeting the liver: Insights from a tertiary center on post-operative hepatic arterial oxaliplatin for metastatic colorectal cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 04, 2025

Showing 1-12 of 37

Last Updated: 09/26/2026